Literature DB >> 21849201

Increased risk of overall and cardiovascular mortality after radical nephrectomy for renal cell carcinoma 2 cm or less.

Max Kates1, Gina M Badalato, Max Pitman, James M McKiernan.   

Abstract

PURPOSE: We used a large, population based registry to assess whether a difference in overall and cardiovascular survival may exist between radical nephrectomy and partial nephrectomy for renal cell carcinoma 2 cm or less.
MATERIALS AND METHODS: From the SEER (Surveillance, Epidemiology and End Results) registry we identified 4,216 patients with histologically confirmed renal cell carcinoma 2 cm or less who were treated with partial or radical nephrectomy. Patient and tumor characteristics were compared between the 2 patient groups. Multivariate logistic regression was done to predict the odds of undergoing radical nephrectomy. Cardiovascular survival and overall survival were compared between the 2 cohorts, adjusting for patient and tumor characteristics.
RESULTS: Overall 2,301 patients (55%) underwent partial nephrectomy. Partial nephrectomy use steadily increased during the study period from 27% of all cases in 1998 to 66% in 2007. Patients who underwent partial nephrectomy were an average of 2.5 years younger than those treated with radical nephrectomy (56.4 vs 58.9 years, p <0.001). They were more likely to be white and from the western or northeastern United States. Older age was the only independent predictor of radical nephrectomy (OR 1.02, 95% CI 1.01-1.03). When controlling for patient characteristics and surgery year, radical nephrectomy was associated with worse overall mortality (HR 2.24, 95% CI 1.75-2.84) and cardiovascular mortality (HR 2.53, 95% CI 1.51-4.23).
CONCLUSIONS: Radical nephrectomy is associated with worse overall and cardiovascular survival compared to partial nephrectomy in patients with localized renal cell carcinoma 2 cm or less. These findings justify the widespread application of nephron sparing techniques to treat localized kidney cancer.
Copyright © 2011 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21849201     DOI: 10.1016/j.juro.2011.05.054

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  15 in total

Review 1.  [Intraoperative frozen section diagnosis of the genitourinary tract].

Authors:  S Bertz; B J Schmitz-Dräger; C Protzel; A Hartmann
Journal:  Pathologe       Date:  2012-09       Impact factor: 1.011

2.  Surgical management of renal cell carcinoma: Canadian Kidney Cancer Forum Consensus.

Authors:  Ricardo A Rendon; Anil Kapoor; Rodney Breau; Michael Leveridge; Andrew Feifer; Peter C Black; Alan So
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

Review 3.  [Standard surgery for small renal masses (<4 cm)].

Authors:  S K Frees; R Mager; H Borgmann; W Jäger; C Thomas; A Haferkamp
Journal:  Urologe A       Date:  2018-03       Impact factor: 0.639

4.  Radical versus partial nephrectomy, chronic kidney disease progression and mortality in US veterans.

Authors:  Elani Streja; Kamyar Kalantar-Zadeh; Miklos Z Molnar; Jaime Landman; Onyebuchi A Arah; Csaba P Kovesdy
Journal:  Nephrol Dial Transplant       Date:  2018-01-01       Impact factor: 5.992

Review 5.  Diagnosis and Treatment of Small Renal Masses: Where Do We Stand?

Authors:  Jerez Izquierdo Tamara; Gómez Rivas Juan; Zondervan Jeannelle Patricia; Vives Dilme Roser; Rodriguez Moisés; Enikeev Dmitry; Serrano Pascual Álvaro; Moreno Sierra Jesús
Journal:  Curr Urol Rep       Date:  2022-05-04       Impact factor: 3.092

6.  Balancing cardiovascular (CV) and cancer death among patients with small renal masses: modification by CV risk.

Authors:  Hiten D Patel; Max Kates; Phillip M Pierorazio; Mohamad E Allaf
Journal:  BJU Int       Date:  2014-07-27       Impact factor: 5.588

7.  Characterization of mild and severe post-radical nephrectomy renal functional deterioration utilizing histopathological evaluation of non-neoplastic nephrectomized renal parenchyma.

Authors:  Takehiro Sejima; Tetsuya Yumioka; Noriya Yamaguchi; Hideto Iwamoto; Toshihiko Masago; Shuichi Morizane; Masashi Honda; Atsushi Takenaka
Journal:  Int J Clin Oncol       Date:  2015-10-08       Impact factor: 3.402

8.  Metabolic imaging with hyperpolarized 13 C pyruvate magnetic resonance imaging in patients with renal tumors-Initial experience.

Authors:  Shuyu Tang; Maxwell V Meng; James B Slater; Jeremy W Gordon; Daniel B Vigneron; Bradley A Stohr; Peder E Z Larson; Zhen Jane Wang
Journal:  Cancer       Date:  2021-04-12       Impact factor: 6.860

9.  Is there a role for neoadjuvant targeted therapy to downsize primary tumors for organ sparing strategies in renal cell carcinoma?

Authors:  A Bex; B K Kroon; R de Bruijn
Journal:  Int J Surg Oncol       Date:  2012-06-20

Review 10.  Partial nephrectomy for metastatic renal cell carcinoma: Where do we stand?

Authors:  Mohammed Shahait; Deborah Mukherji; Yaser El-Hout
Journal:  Indian J Urol       Date:  2015 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.